社会因素对 status epilepticus 的结果的影响
1Homerton University Hospital NHS Foundation Trust, Homerton Way, London E9 6SR, UK; UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.
Epilepsy & behavior : E&B
|November 1, 2024
概括
像种族这样的社会因素会影响 status epilepticus (SE) 的结果. 黑人人口的SE发病率较高,死亡率较低. 教育水平和社会剥夺也会影响的预后.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 社会学 社会学 社会学
背景情况:
- 状态 (SE) 是一种具有显著发病率和死亡率的神经紧急情况.
- 社会人口因素对SE发病率和预后的影响尚未完全理解.
- 了解这些差异对于有针对性的公共卫生干预至关重要.
研究的目的:
- 审查现有证据,以了解社会因素对 status epilepticus (SE) 的预后的影响.
- 具体研究性别,种族,教育水平和社会剥夺对SE发病率和死亡率的影响.
- 确定与这些社会决定因素相关的SE结果中的差异.
主要方法:
- 系统的文献审查检查社会因素和状态.
- 对聚焦于性别,种族,教育和社会剥夺与SE发病率和预后相关的研究进行分析.
- 包括在第九届伦敦-因斯布鲁克关于 status epilepticus 和急性发作讨论会上提出的数据.
主要成果:
- 在SE发病率和死亡率中观察到显著的种族差异,特别是在美国,黑人人口的发病率更高,死亡率更低.
- 低教育程度与的死亡率增加有关,虽然不是特定的SE.
- 社会剥夺与成年人有明显的关联,缺乏证据表明可能与SE死亡率更高的潜在联系,可能与其他因素有关.
结论:
- 种族是影响 status epilepticus 结果的重要因素,需要对潜在机制进行进一步调查.
- 较低的教育水平和社会贫困可能会导致的结果较差,因此需要有针对性的支持和干预措施.
- 社会决定因素的复杂相互作用需要全面的战略来缓解SE发病率和死亡率的差异.
相关概念视频
01:13Seizures: Classification
303
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
303
01:29Psychological and Sociocultural Causes of Schizophrenia
80
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
80
01:24Arteries of the Lower Limbs
178
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
178
01:30Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
01:20Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
255
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
255